Paul Hartmann AG (FRA:PHH2) Total Stockholders Equity: €1,228 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PHH2 Paul Hartmann AG FRA:PHH2
64 GF Score
Price €201.00
GF Value €226.94
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Paul Hartmann AG Total Stockholders Equity?

Paul Hartmann AG FRA:PHH2 +1.01% 64 Total Stockholders Equity is €1,228 Mil as of Jun. 2026. GuruFocus rates FRA:PHH2 with a GF Score™ of 64/100 and a GF Value™ of €226.94 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Paul Hartmann AG's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €1,228 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Paul Hartmann AG's Book Value per Share for the quarter that ended in Jun. 2026 was €345.79. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Paul Hartmann AG's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.00.

Paul Hartmann AG  (FRA:PHH2) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Paul Hartmann AG's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1228.232-0)/3.552
=345.79

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Paul Hartmann AG's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 1228.232
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paul Hartmann AG Total Stockholders Equity Related Terms

Paul Hartmann AG Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Paul Hartmann AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Paul Hartmann AG Total Stockholders Equity Chart

Paul Hartmann AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,043.12 1,078.96 1,063.40 1,148.55 1,174.65

Paul Hartmann AG Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,084.17 1,148.55 1,126.18 1,174.65 1,228.23
FRA:PHH2
64GF Score
Paul Hartmann AG FRA:PHH2
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €1,228 Mil mean?
Paul Hartmann AG (FRA:PHH2) has a Total Stockholders Equity of €1,228 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Paul Hartmann AG and its competitors.
Is Paul Hartmann AG's Total Stockholders Equity too high?
Paul Hartmann AG's current Total Stockholders Equity is €1,228 Mil. Overall, Paul Hartmann AG has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's Total Stockholders Equity compare to ISRG and BDX?
Paul Hartmann AG's Total Stockholders Equity of €1,228 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Paul Hartmann AG and its competitors. Paul Hartmann AG's current Total Stockholders Equity is €1,228 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (FRA:PHH2) is currently considered Modestly Undervalued. The stock's GF Value™ is €226.94, compared to a current price of €201.00 — trading 11.4% below its estimated fair value. The current Total Stockholders Equity is €1,228 Mil. Paul Hartmann AG's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Paul Hartmann AG (FRA:PHH2), the current Total Stockholders Equity is €1,228 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Paul Hartmann AG (FRA:PHH2) Overvalued in 2026?

Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued. The current stock price of €201.00 is trading 11.4% below its estimated GF Value™ of €226.94. GuruFocus considers Paul Hartmann AG to be Modestly Undervalued.

Key valuation signals for FRA:PHH2:

  • Total Stockholders Equity: €1,228 Mil
  • GF Value™: €226.94 vs. price of €201.00 (11.4% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the FRA:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Paul Hartmann AG Business Description

Other Exchanges PHH2:Germany
Address Paul-Hartmann-Strasse 12, Heidenheim, DEU, 89522
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
64GF Score

Get the complete analysis for FRA:PHH2

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€201.00
Price
€226.94
GF Value